Improving the high variable bioavailability of griseofulvin by SEDDS

Chemical and Pharmaceutical Bulletin

Volumn 55, Issue 12, 2007, Pages 1713-1719

  Arida, Adi Issam ^a   Al Tabakha, Moawia Mohammed ^b   Hamoury, Hantash Abdel Jalil ^a  

^a PHILADELPHIA UNIVERSITY   (Jordan)

^b AJMAN UNIVERSITY   (United Arab Emirates)

Author keywords

Bioavailability; Dissolution; Griseofulvin; Self emulsifying drug delivery system

Indexed keywords

GRISEOFULVIN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DISSOLUTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STRUCTURE; FOOD INTAKE; INTESTINE FLUID; MALE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; RAT; STOMACH JUICE; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; ANTIBIOTICS, ANTIFUNGAL; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; BIOPHARMACEUTICS; DRUG DELIVERY SYSTEMS; EMULSIONS; EXCIPIENTS; FOOD-DRUG INTERACTIONS; GRISEOFULVIN; MALE; PARTICLE SIZE; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY; SOLVENTS;

EID: 36849061528     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.55.1713     Document Type: Article

References (42)

1. Charman S. A., Charman W. N., Rogge M. C., Wilson T. D., Dutko F. J., Pouton C. W., Pharm. Res., 9, 87-93 (1992).
2. Pouton C. W., Int. J. Pharm., 27, 335-348 (1985).
3. Shah N. H., Carvajal M. T., Patel C. I., Infeld N. H., Malick A. W., Int. J. Pharm., 106, 15-23 (1994).
4. Pouton C. W., Charman W. N., Adv. Drug Deliv. Rev., 25, 1-2 (1997).
5. Pouton C. W., Adv. Drug Deliv. Rev., 25, 47-58 (1997).
6. Kim C. K., Cho Y. J., Gao Z. G., J. Controlled Release, 70, 149-155 (2001).
7. Constantinides P. P., Pharm. Res., 12, 1561-1572 (1995).
8. Craig D. Q. M., Barker S. A., Banning D., Booth S. W., Int. J. Pharm., 114, 103-110 (1995).
9. Porter C. J., Charman W. N., Adv. Drug Deliv. Rev., 50 (Suppl. 1), S127-S147 (2001).
10. Itoh K., Tozuka Y., Oguchi T., Yamamoto K., Int. J. Pharm., 238, 153-160 (2002).
11. Kim H. J., Yoon K. A., Hahn M., Park E. S., Chi S. C., Drug Dev. Ind. Pharm., 26, 523-529 (2000).
12. Kommuru T. R., Gurley B., Khan M. A., Reddy I. K., Int. J. Pharm., 212, 233-246 (2001).
13. Julianto T., Yuen K. H., Noor A. M., Int. J. Pharm., 200, 53-57 (2000).
14. Khoo S. H., Humberstone A. J., Porter C. J. H., Edwards G. A., Charman W. N., Int. J. Pharm., 167, 155-164 (1998).
15. Gao Z. G., Choi H. G., Shin H. J., Int. J. Pharm., 161, 75-86 (1998).
16. Lin C., Magat J., Chang R., McGlotten J., Symchowicz S.. J. Pharmacol. Exp. Ther., 187, 415-422 (1973).
17. Drug Bank Griseofulvin (APRD01004) http://redpoll.pharmacy.ualberta.ca/ drugbank/cgi-bin/getCard.cgi? CARD APRD01004.txt (accessed 2 January 2007).
18. Gull K., Trinci A. P. J., Nature (London), 244, 292-294 (1973).
19. Korting H. C., Schäfer-Korting M., Zienicke H., Georgii A., Ollert M. W., Antimicrob. Agents Chemother., 37, 2064-2068 (1993).
20. Dongowski G., Fritzsch B., Giessler J., Härtl A., Kuhlmann O., Neubert R. H. H., Eur. J. Pharm. Biopharm., 60, 147-151 (2005).
21. Amidon G. L., Lennernas H., Shah V. P., Crison J. R., Pharm. Res., 12, 413-420 (1995).
22. Six K., Verreck G., Peeters J., Brewster M., Van Den Mooter G., J. Pharm. Sci., 93, 124-131 (2004).
23. Grifulvin V (Ortho), "PDR Physicians desk reference," 43rd ed., Medical Economics Company, Oradell, NJ, 1989, p. 1515.
24. Fulvicin-U/F (Schering), "PDR Physicians desk reference," 43rd ed., Medical Economics Company, Oradell, NJ, 1989, p. 1923.
25. Lin C., Lim J., DiGiore C., Gural R., Symchowicz S., J. Int. Med. Res., 10, 274-277 (1982).
26. Straughn A. B., Meyer M. C., Raghow G., Rotenberg K., J. Pharmacokinet. Biopharm., 8, 347-362 (1980).
27. Maeda T., Takenaka H., Yamahira Y., Noguchi T., J. Pharm. Sci., 68, 1286-1289 (1979).
28. Chiba Y., Kohri N., Iseki K., Miyazaki K., Chem. Pharm. Bull., 39, 2158-2160 (1991).
29. Kislalioglu M. S., Khan M. A., Blount C., Goettsch R. W., Bolton S., J. Pharm. Sci., 80, 799-804 (1991).
30. Ho H. O., Su H. L., Tsai T., Sheu M. T., Int. J. Pharm., 139, 223-229 (1996).
31. Moyano J. R., Arias M. J., Gines J. M., Rabasco A. M., Drug Dev. Ind. Pharm., 23, 379-385 (1997).
32. Okonogi S., Oguchi T., Yonemochi E., Puttipipatkhachorn S., Yamamoto K., Int. J. Pharm., 156, 175-180 (1997).
33. Yoo S. D., Lee S. H., Kang E., Jun H., Jung J. Y., Park J. W., Lee K. H., Drug Dev. Ind. Pharm., 26, 27-34 (2000).
34. Gursoy R. N., Benita S., Biomed. Pharmacother., 58, 173-182 (2004).
35. Hong J. Y., Kim J. K., Song Y. K., Park J. S., Kim C. K., J. Controlled Release, 110, 332-338 (2006).
36. Garcia-Celma M. J., Indust. Appl. Microemulsions, 66, 123-145 (1997).
37. Trotta M., Pattarino F., Grosa G., Int. J. Pharm., 174, 253-259 (1998).
38. Mehdizadeh M., Grant D. J., J. Pharm. Sci., 73, 1195-1203 (1984).
39. Corvis Y., Barzyk W., Brezesinski G., Mrabet N., Badis M., Hecht S., Rogalska E., Langmuir, 22, 7701-7711 (2006).
40. Tarr B. D., Yalkowsky S. H., Pharm. Res., 6, 40-43 (1989).
41. Humberstone A. J., Charman W. N., Adv. Drug Deliv. Rev., 25, 103-127 (1997).
42. O'Driscoll C. M., Eur. J. Pharm. Sci., 15, 405-415 (2002).